eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2024
vol. 10
 
Share:
Share:
Original paper

Have serum vitamin D and ferritin a role in predicting the prognosis of autoimmune hepatitis treatment in children?

Salma Abdel Megeed Nagi
1
,
Sania Ali Yehia
2
,
Yasmen Abdelaziz Elhagali
3
,
Shimaa Saad Elkholy
4
,
Basma Mahmoud Abd-Elaati
1

1.
Pediatric Hepatology, Gastroenterology and Nutrition Department, National Liver Institute, Menoufia University, Shebin Elkom, Menoufia, Egypt
2.
Epidemiology and Preventive Medicine Department, National Liver Institute, Menoufia University, Shebin Elkom, Menoufia, Egypt
3.
Laboratory Medicine Department, National Liver Institute, Menoufia University, Shebin Elkom, Menoufia, Egypt
4.
Pathology Department, National Liver Institute, Menoufia University, Shebin Elkom, Menoufia, Egypt
Clin Exp HEPATOL 2024; 10, 1: 53–61
Online publish date: 2024/03/28
Article file
- Have serum.pdf  [0.61 MB]
Get citation
 
PlumX metrics:
 
1. Deng G, Li Y, Ma S, et al. Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress. Free Radic Biol Med 2020; 148: 151-161.
2. Cassim S, Bilodeau M, Vincent C, et al. Novel immunotherapies for autoimmune hepatitis. Front Pediatr 2017; 26: 5-8.
3. Sîrbe C, Badii M, Crişan TO, et al. Detection of novel biomarkers in pediatric autoimmune hepatitis by proteomic profiling. Int J Mol Sci 2023; 24: 7479.
4. Aljumah AA, Al Jarallah B, Albenmousa A, et al. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi J Gastroenterol 2018; 24 (Suppl 1): S1-S20.
5. Yuan X, Duan SZ, Cao J, et al. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. Eur J Gastroenterol Hepatol 2019; 31: 1467-1474.
6. Park SW, Um SH, Lee HA, et al. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Clin Mol Hepatol 2016; 22: 281-285.
7. van Gerven NM, Verwer BJ, Witte BI, et al. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission. J Hepatol 2013; 58: 141-147.
8. Kalla R, Kennedy NA, Ventham NT, et al. Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases. Am J Gastroenterol 2016; 111: 1796-1805.
9. Taubert R, Hardtke-Wolenski M, Noyan F, et al. Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLoS One 2017; 12: e0179074.
10. Bohne F, Martínez-Llordella M, Lozano JJ, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368-382.
11. Ebadi M, Bhanji RA, Mazurak VC, et al. Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis. Aliment Pharmacol Ther 2019; 49: 173-182.
12. Tao S, Zhang H, Zhao Q, et al. Correlation of vitamin D with inflammatory factors, oxidative stress, and T cell subsets in patients with autoimmune hepatitis. Exp Ther Med 2020; 19: 3419-3424.
13. Hennes EM, Zeniya M, Czaja AJ, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
14. Pape S, Snijders RJ, Gevers TJ, et al. Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group. J Hepatol 2022; 76: 841-849.
15. van Gerven NM, de Boer YS, Mulder CJ, et al. Auto immune hepatitis. World J Gastroenterol 2016; 22: 4651-4661.
16. Luong KVQ, Nguyen LT. The role of vitamin D in autoimmune hepatitis. J Clin Med Res 2013; 5: 407-415.
17. O’Brien MA, Jackson MW. Vitamin D and the immune system: beyond rickets. Vet J 2012; 194: 27-33.
18. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-520.
19. Saron ML, Godoy HT, Hessel G. Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D and E. Arq Gastroenterol 2009; 46: 62-68.
20. Anderson GJ, Frazer DM. Hepatic iron metabolism. Semin Liver Dis 2005; 25: 420-432.
21. Chen Q, Gao M, Yang H, et al. Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis. BMC Gastroenterol 2022; 22: 23.
22. Efe C, Kav T, Aydin C, et al. Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci 2014; 59: 3035-3042.
23. Behairy BE, Sira MM, Zalata KR, et al. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: does etiology matter. World J Gastroenterol 2016; 22: 4238-4249.
24. Pokorska-Śpiewak M, Kowalik-Mikołajewska B, Aniszewska M, et al. Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C. BMC Infect Dis 2017; 17: 361.
25. Dhole SD, Kher AS, Ghildiyal RG, et al. Chronic liver diseases in children: clinical profile and histology. J Clin Diagn Res 2015; 9: SC04.
26. Vitfell-Pedersen J, Jørgensen MH, Müller K, et al. Autoimmune hepatitis in children in Eastern Denmark. J Pediatr Gastroenterol Nutr 2012; 55: 376-379.
27. Ngu JH, Gearry RB, Frampton CM, et al. Predictors of poor outcome in patients with autoimmune hepatitis: a population‐based study. Hepatology 2013; 57: 2399-2406.
28. Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011; 8: 320-329.
29. Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis 2005; 40: 834-841.
30. Roberts EA. Autoimmune hepatitis from the paediatric perspective. Liver Int 2011; 31: 1424-1431.
Copyright: © 2024 Clinical and Experimental Hepatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.